本页面由Tiger Trade Technology Pte. Ltd.提供服务

PHAXIAM THERAPEUTICS S A SPON ADR EACH REPR 1 ORD

3.10
0.0000
成交量:- -
成交额:- -
市值:1,883.22万
市盈率:-1.48
高:3.10
开:3.10
低:3.10
收:3.10
52周最高:3.10
52周最低:3.10
股本:607.49万
流通股本:450.70万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-2.0974
每股收益(LYR):-0.0786
净资产收益率:-38.62%
总资产收益率:-15.05%
市净率:0.44
市盈率(LYR):-39.46

数据加载中...

2024/03/04

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/04

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/04

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/04

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/04

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/01

自愿退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2023/03/28

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2022/12/23

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2022/06/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2022/04/27

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]